Skip to content
10-Q

Quarterly Report

MARIMED INC. MRMD

0001522767-26-000073

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 399.27M sh
Shares Diluted Q1 2026 · Mar 31, 2026 397.45M sh
Shares Diluted Q1 2026 · Mar 31, 2025 382.56M sh
Capex Q1 2026 · Mar 31, 2026 $373K
Capex Q1 2026 · Mar 31, 2025 $266K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $949K
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.29M
Long Term Debt Q1 2026 · Mar 31, 2026 $82.54M
Current Liabilities Q1 2026 · Mar 31, 2026 $63.76M
Current Liabilities Q1 2026 · Dec 31, 2025 $59.07M
Total Liabilities Q1 2026 · Mar 31, 2026 $147.74M
Total Liabilities Q1 2026 · Dec 31, 2025 $137.83M
Current Assets Q1 2026 · Mar 31, 2026 $60.79M
Current Assets Q1 2026 · Dec 31, 2025 $59.29M
Total Assets Q1 2026 · Mar 31, 2026 $201.19M
Total Assets Q1 2026 · Dec 31, 2025 $202.57M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.01
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.01
Eps Basic Q1 2026 · Mar 31, 2026 −$0.01
Eps Basic Q1 2026 · Mar 31, 2025 −$0.01
Net Income Q1 2026 · Mar 31, 2026 −$3.79M
Net Income restated Q1 2026 · Mar 31, 2025 −$5.51M
Operating Income Q1 2026 · Mar 31, 2026 $125K
Operating Income restated Q1 2026 · Mar 31, 2025 −$910K
Gross Profit Q1 2026 · Mar 31, 2026 $15.28M
Gross Profit restated Q1 2026 · Mar 31, 2025 $15.09M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $24.21M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $22.82M
Revenue Q1 2026 · Mar 31, 2026 $39.48M
Revenue restated Q1 2026 · Mar 31, 2025 $37.91M